X-linked protoporphyria (XLP)

Clinical trials for X-linked protoporphyria (XLP) explained in plain language.

Never miss a new study

Get alerted when new X-linked protoporphyria (XLP) trials appear

Sign up with your email to follow new studies for X-linked protoporphyria (XLP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New pill could let Sun-Sensitive patients enjoy the outdoors

Disease control Ongoing

This Phase 3 trial tests whether bitopertin, a daily pill, can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will take bitopertin or a placebo for 6 months. …

Matched conditions: X-LINKED PROTOPORPHYRIA (XLP)

Phase 3 • Sponsor: Disc Medicine, Inc • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

X-linked protoporphyria (XLP)

Get alerted when new X-linked protoporphyria (XLP) trials appear

New pill could let Sun-Sensitive patients enjoy the outdoors